Literature DB >> 11606112

Intratumoral sickling in a patient with cervix cancer and sickle trait: effect on blood flow and oxygenation.

M Milosevic1, I Quirt, W Levin, A Fyles, L Manchul, W Chapman.   

Abstract

BACKGROUND: Sickle trait affects approximately 8% of the black population in the United States and up to 40% of individuals in some parts of tropical Africa, but rarely causes clinically significant illness. This report provides the first conclusive evidence that erythrocytes in patients with sickle trait may sickle in the microvasculature of solid tumors, leading to impaired perfusion and hypoxia. CASE: A black woman who was sickle trait positive presented with stage IIIB squamous cell carcinoma of the cervix. A biopsy showed extensive intravascular sickling of erythrocytes. An aspirate of blood obtained directly from the tumor also showed numerous sickled cells. A peripheral blood smear was normal. Direct measurement of oxygen tension using the Eppendorf electrode revealed the tumor to be markedly hypoxic, with 93% of a total of 142 individual oxygen reading <5 mm Hg.
CONCLUSIONS: Erythrocytes in patients with sickle trait may sickle in the microvasculature of solid tumors and contribute to reduced blood flow and the development of hypoxia. Hypoxia is a strong independent prognostic factor in patients with cervix cancer, and further study is needed to evaluate the impact of intratumoral sickling on long-term outcome. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11606112     DOI: 10.1006/gyno.2001.6426

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

Review 1.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

Review 2.  Adverse events in cancer patients with sickle cell trait or disease: case reports.

Authors:  Helen Swede; Biree Andemariam; David I Gregorio; Beth A Jones; Dejana Braithwaite; Thomas E Rohan; Richard G Stevens
Journal:  Genet Med       Date:  2014-08-21       Impact factor: 8.822

3.  Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response.

Authors:  David S Terman; Benjamin L Viglianti; Rahima Zennadi; Diane Fels; Richard J Boruta; Hong Yuan; Mathew R Dreher; Gerald Grant; Zahid N Rabbani; Ejung Moon; Lan Lan; Joseph Eble; Yiting Cao; Brian Sorg; Kathleen Ashcraft; Greg Palmer; Marilyn J Telen; Mark W Dewhirst
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.